The induction and function of the anti-inflammatory fate of TH17 cells

Xu, Hao; Agalioti, Theodora; Zhao, Jun; Steglich, Babett; Wahib, Ramez; Vesely, Maria Carolina Amezcua; Bielecki, Piotr; Bailis, Will; Jackson, Ruaidhri; Perez, Daniel; Izbicki, Jakob; Licona-Limón, Paula; Kaartinen, Vesa; Geginat, Jens; Esplugues, Enric; Tolosa, Eva; Huber, Samuel; Flavell, Richard A.; Gagliani, Nicola

doi:10.1038/s41467-020-17097-5

Download PDF

Article
Open access
Published: 03 July 2020

The induction and function of the anti-inflammatory fate of T_H17 cells

Hao Xu¹^na1,
Theodora Agalioti²^na1,
Jun Zhao¹,
Babett Steglich³,
Ramez Wahib²,
Maria Carolina Amezcua Vesely¹,
Piotr Bielecki¹,
Will Bailis ORCID: orcid.org/0000-0001-9420-6250^4,5,
Ruaidhri Jackson¹,
Daniel Perez²,
Jakob Izbicki²,
Paula Licona-Limón⁶,
Vesa Kaartinen ORCID: orcid.org/0000-0002-9432-510X⁷,
Jens Geginat^8,9,
Enric Esplugues¹⁰,
Eva Tolosa¹¹,
Samuel Huber³,
Richard A. Flavell ORCID: orcid.org/0000-0003-4461-0778^1,12 &
…
Nicola Gagliani ORCID: orcid.org/0000-0001-8514-1395^2,3,13

Nature Communications volume 11, Article number: 3334 (2020) Cite this article

9123 Accesses
38 Citations
6 Altmetric
Metrics details

Subjects

Abstract

T_H17 cells exemplify environmental immune adaptation: they can acquire both a pathogenic and an anti-inflammatory fate. However, it is not known whether the anti-inflammatory fate is merely a vestigial trait, or whether it serves to preserve the integrity of the host tissues. Here we show that the capacity of T_H17 cells to acquire an anti-inflammatory fate is necessary to sustain immunological tolerance, yet it impairs immune protection against S. aureus. Additionally, we find that TGF-β signalling via Smad3/Smad4 is sufficient for the expression of the anti-inflammatory cytokine, IL-10, in T_H17 cells. Our data thus indicate a key function of T_H17 cell plasticity in maintaining immune homeostasis, and dissect the molecular mechanisms explaining the functional flexibility of T_H17 cells with regard to environmental changes.

Intricacies of TGF-β signaling in Treg and Th17 cell biology

Article Open access 23 May 2023

Junying Wang, Xingqi Zhao & Yisong Y. Wan

TH17 cell heterogeneity and its role in tissue inflammation

Article 03 January 2023

Alexandra Schnell, Dan R. Littman & Vijay K. Kuchroo

Plasticity of innate lymphoid cell subsets

Article 27 February 2020

Suzanne M. Bal, Korneliusz Golebski & Hergen Spits

Introduction

The consequences of dysfunctional immune adaptation are clear: the immune cells either fail to mount a protective response to lethal infections, or they overreact to non-harmful antigens and in doing so, induce disparate immune mediated inflammatory diseases (IMIDs). It is therefore both fundamentally and clinically relevant to reveal the molecular mechanisms underlying this phenomenon of immune adaptation.

T_H17 cells—a subset of CD4⁺ T cells—exemplify immune adaptation. On the one hand, T_H17 cells can have a full effector function protecting the host from pathogens with the associated risk of developing IMIDs^1,2,3,4,5. On the other hand, T_H17 cells can also acquire an anti-inflammatory fate characterized by secretion of the anti-inflammatory cytokine, IL-10^6,7,8. However, the relevance of this T_H17 anti-inflammatory fate and the consequences of its impairment have not yet been fully explored. T_H17 cells are abundant in the intestine⁶, but it remains to be tested whether by acquiring an anti-inflammatory fate, they contribute to intestinal immune homeostasis by blocking the development of a pathological response and preserving the tissue integrity. Furthermore, whether this anti-inflammatory fate negatively impacts T_H17 mediated immunity to pathogens is also unknown.

Finally, the exact molecular mechanism behind this cellular adaptation also remains to be clarified. Even though the key molecular pathways for the differentiation of CD4⁺ T cells into T_H17 cells have been studied extensively^9,10,11,12, investigation into the mechanisms that promote the anti-inflammatory fate of mature T_H17 cells has just begun^{7,13,14,15,16}. On the basis of in vitro screenings, we proposed that TGF-β controls the expression of IL-10 in CD4⁺ T cells during their in vitro differentiation into T_H17 cells^7,17. However, whether TGF-β also plays a key role in vivo and on already matured T_H17 cells, and through which molecular signalling, remain to be studied.

It is known that upon engagement of TGF-β with TGFBR1/R2 on CD4⁺ T cells, TGFBR2 trans phosphorylates TGFBR1, which propagates signalling by phosphorylating Smad2 and Smad3. Once Smad2 and Smad3 form a heteromeric complex with the common mediator Smad4, they translocate to the nucleus to trans-activate several genes. It has been shown that while Smad2 promotes RORγt activity (i.e. the key transcriptional factor of T_H17 cell differentiation), Smad3 impairs it^18,19. Furthermore, Smad4 and SKI protein bind together and repress the Rorγt promoter, thus when Smad4 gene is deleted from CD4⁺ T cells, IL-6 can induce T_H17 cells without TGF-β². Interestingly, in embryonic stem cells, Smad2 and Smad3 complex cannot access the target genes without TIF1-γ²⁰. Therefore, TIF1-γ is considered an alternative pathway to Smad4. Indeed, Smad2/Smad3-TIF1-γ complex controls the differentiation of hematopoietic stem/progenitor cells in response to TGF-β, while Smad2/3-Smad4 complex regulates the proliferation of those cells²¹. Recent data suggest that the deletion of Tif1g in CD4⁺ T cells decreases the expression of IL-17A and increases IL-10 while the cells are differentiating into T_H17 cells²². Of note, this latter study is performed either in vitro or it addresses the role of TIF1-γ during the differentiation of CD4⁺ T cells into T_H17 cells, rather than in vivo or on mature T_H17 cells. Therefore, the role of TGF-β on mature T_H17 cells and through which pathways TGF-β signals, are still unclear.

In this study, we find that the anti-inflammatory fate of T_H17 cells contributes to maintaining intestinal immune homeostasis. In addition, our data show that the anti-inflammatory fate of T_H17 cells impairs an effective immune response to S. aureus, but is essential to control the resolution of the intestinal inflammation. Furthermore, we show that all this is orchestrated by TGF-β via Smad3 and Smad4 signalling and not via TIF1-γ. Finally, we extended part of these findings to human biology. Together, these observations broaden our understanding about how late fate decision of T_H17 cells is controlled and about the physiological implications behind T_H17 plasticity.

Results

T_H17 derived IL-10 contributes to intestinal homeostasis

We previously showed that some T_H17 cells can express IL-10 (IL-10⁺ T_H17) and eventually fully convert into bona fide T_R1 cells (T_R1^exTH17): the anti-inflammatory fate of T_H17 cells^6,7. Of note, the identity of these T_R1^exTH17 cells has been previously shown at both the transcriptional and functional levels⁷. However, the spatial distribution of these different cell statuses (i.e. IL-10⁺ T_H17 and T_R1^exTH17 cells) remained to be defined. We used the Fate⁺ (Il17a^Cre/Katushka, Rosa26-STOP^Flox/Flox YFP (R26^YFP), Il10^eGFP, Foxp3^RFP) mice and assessed the presence of T_H17 (Foxp3^RFP− IL-17A^Katushka+ IL-10^eGFP− R26^YFP+), IL-10⁺ T_H17 cells (Foxp3^RFP− IL-17A^Katushka+ IL-10^eGFP+ R26^YFP+) and T_R1^exTH17 cells (Foxp3^RFP− IL-17A^Katushka− IL-10^eGFP+ R26^YFP+) in lymphoid and in intestinal tissues. We observed that the majority of these two T_H17-derived IL-10 producing cell populations (i.e. IL-10⁺ T_H17 cells and T_R1^exTH17 cells) reside in the Peyer’s Patches (PP) and in the ileum (Fig. 1a). Considering that the small intestine and PP host several other types of anti-inflammatory cells, such as Foxp3⁺ Treg and T_R1 cells, which also secrete high levels of IL-10^23,24,25, we wondered whether the anti-inflammatory fate of T_H17 cells is redundant for the intestinal homeostasis. To this end, we crossed Il17a^Cre mice with Il10^Flox/Flox and R26^YFP mice (from here on referred to as Il17a^Cre Il10^Flox/Flox) (Supplementary Fig. 1a). First, we confirmed the efficiency of IL-10 deletion in T_H17 cells in vivo and in vitro (Supplementary Fig. 1b–e). Then we investigated whether intestinal homeostasis in these mice was altered. Although we did not observe any obvious intestinal tissue damage microscopically (Supplementary Fig. 1f), many pro-inflammatory genes such as Il1b, Il17f, Cxcl1, Ifng and Tnfa are elevated in the intestinal tissues of Il17a^Cre Il10^Flox/Flox mice, compared to their littermate control mice (Il17a^Cre Il10^Wt/Wt) under steady state conditions (Fig. 1b). Furthermore, a more detailed cellular analysis revealed that under steady state conditions, there was an accumulation of T_H17 and T_H1/T_H17 cells in the small intestine of the Il17a^Cre Il10^Flox/Flox mice compared to their wild-type littermate controls. Of note, the T_H1 cell population was comparable in frequency and number between the Il17a^Cre Il10^Flox/Flox and control mice, suggesting that T_H17 cell derived IL-10 has a specific capacity to regulate T_H17 cell expansion in the intestine (Fig. 1c–e).

Next, we profiled the IL-10 expression in different types of immune cells to assess the different potential contribution to the phenotype observed in the Il17a^Cre Il10^Flox/Flox mice. We observed that more than 90% of the cells that co-express IL-10 and YFP (indicating IL-17A production) in the small intestine are CD4⁺ T cells (Supplementary Fig. 1g).

Finally, we tested whether Il17a^Cre Il10^Flox/Flox mice acquired an extra intestinal spontaneous immune dysregulation, but we could not observe any immune abnormality in the thymus, spleen and other peripheral lymphoid organs (Supplementary Fig. 2).

These data reveal the distribution of the IL-10⁺ T_H17 cells and T_R1^exTH17 cells along the small intestinal tract. Moreover, these data suggest that the anti-inflammatory fate of T_H17 cells plays a non-redundant role in maintaining the cellular and molecular immune homeostasis in the small intestine.

IL-10 deletion in T_H17 enhances antibacterial immunity

We next hypothesized that IL-10 deletion in IL-17A producing cells may lead to more efficient immunity at the expense of immunological tolerance. To test this hypothesis, we first used a S. aureus infection mouse model and then an intestinal inflammation mouse model followed by a spontaneous resolution phase.

We and others have previously shown that intravenous infection of S. aureus promotes the accumulation and activation of IL-10-producing T_H17 cells at the intestinal barrier^6,7,26. Mechanistically we showed that the superantigen of S. aureus, staphylococcus aureus enterotoxin B (SEB), induces a cytokine storm and rapid induction/expansion of intestinal T_H17 cells⁶. Here we first immunized the Il17a^Cre Il10^Flox/Flox mice with heat killed S. aureus and then infected them to test the efficiency of bacterial clearance (Fig. 2a). We observed that the Il17a^Cre Il10^Flox/Flox mice had a lower bacterial burden compared to control mice (Il17a^Cre Il10^Wt/Wt) in the spleen, small intestine and the liver (Fig. 2b). We also confirmed the frequency and the number of both T_H17 and T_H1/T_H17 in Il17a^Cre Il10^Flox/Flox mice were increased after treatment, as already observed under steady state conditions (Fig. 2c–e). These results suggest that IL-10 deletion in IL-17A producing cells leads to a more efficient immune response against S. aureus.

**Fig. 2: IL-10 deletion in T_H17 enhances antibacterial immunity.**

IL-10 deletion in T_H17 impairs intestinal immune regulation

Next, we tested whether IL-17A-producing cell derived IL-10 plays an essential role during the resolution of inflammation in the small intestine. Thus, we challenged mice with anti-CD3 monoclonal antibody (mAb) treatment, a mouse model that we and others have previously established to induce a transient inflammation in the small intestine followed by the re-establishment of immunological tolerance^6,7,25,27,28. We found that Il17a^Cre Il10^Flox/Flox mice were more susceptible to inflammation induced weight loss compared to control mice (Il17a^Cre Il10^Wt/Wt) (Fig. 3a). Furthermore, the small intestines of the Il17a^Cre Il10^Flox/Flox mice showed more severe tissue damage, represented by disrupted villi structures and edema compared to control mice (Fig. 3b). In addition, we observed a selective accumulation of T_H17 cells and T_H17/T_H1 cells in the intestine of the Il17a^Cre Il10^Flox/Flox mice (Fig. 3c–e). We next questioned whether a different expression of IL-10R among the T_H17, T_H17/T_H1 and T_H1 cells could justify the selective accumulation of T_H17 cells and T_H17/ T_H1 but not of T_H1 cells in the Il17a^Cre Il10^Flox/Flox mice. In line with what we published previously²⁵, we indeed observed that T_H17 and T_H17/T_H1 cells express higher levels of IL-10R compared to T_H1 cells (Supplementary Fig. 3a, b).

Collectively, these data indicate that the lack of IL-10 expression in IL-17A producing cells promotes immunity against S. aureus infection, but leads to impaired resolution of the immune response.

TGF-βRII is required for mature T_H17 cells to produce IL-10

Despite the fact that the molecular signals inducing IL-10 in naïve CD4⁺ T cells have been largely explored, the molecular mechanisms that control IL-10 production in mature T_H17 cells in vivo remain unknown. TGF-β is an obvious candidate considering its effect on naive CD4⁺ T cells. To this end, we first differentiated T_H17 cells in vitro, FACS sorted IL-17A producing CD4⁺ T cells and then re-stimulated these cells in the presence of increasing doses of TGF-β. These results confirmed our previous findings⁷ and further showed that TGF-β promotes IL-10 production also in mature T_H17 cells in a concentration-dependent manner (Supplementary Fig. 4a–d). However, this was an in vitro experiment and whether this is also the case in vivo remained to be tested. Therefore, we tested the role of TGF-β on mature T_H17 cells using a loss-of-function approach. To this end, we crossed Tgfbr2^Flox/Flox with the Fate⁺ mice (Supplementary Fig. 5a). This newly generated Tgfbr2^Flox/Flox Fate⁺ mouse model allowed us to specifically and selectively delete Tgfbr2 gene in IL-17A-producing cells, and in the meantime to track the T_H17 cell fate as well as cytokine profile. We first confirmed that the deletion of Tgfbr2 occurs in a T_H17-specific manner in Tgfbr2^Flox/Flox Fate⁺ (Supplementary Fig. 5b). Next, we tested whether Tgfbr2-deficient T_H17 cells have any impairment in up-regulating IL-10 expression when cultured in vitro. We found that both the IL-10⁺ T_H17 population and T_R1^exTH17 population were reduced in cultured CD4⁺ T cells isolated from Tgfbr2^Flox/Flox Fate⁺ mice compared to CD4⁺ T cells isolated from littermate controls (Fig. 4a, b). Of note, we didn’t observe an obvious defect of primary T_H17 cell differentiation with Tgfbr2^Flox/Flox Fate⁺ cells (Supplementary Fig. 5c, d), which is in line with the previous observation that IL-17A^Cre-mediated gene deletion did not affect primary T_H17 cell proliferation and differentiation²⁹.

Finally, we examined whether T_H17 cells require TGF-βRII in order to produce IL-10 in vivo. We observed that under steady state conditions, intestinal CD4⁺ T cells marked by YFP (indicating Tgfbr2 deletion) from Tgfbr2^Flox/Flox Fate⁺ mice had an obvious impairment in IL-10 and IL-17A production compared to those cells isolated from Tgfbr2^Wt/Wt Fate⁺ mice (Supplementary Fig. 5e–g). Since TGF-β promotes the expression of Foxp3, as a control we tested whether the small expression of Foxp3⁺ among the intestinal R26^YFP+ CD4⁺ T cells was dysregulated in the Tgfbr2^Flox/Flox Fate⁺ mice. However, we did not observe any statistically significant dysregulation of Foxp3 and more importantly no difference in the number of Foxp3⁺ YFP⁺ cells between the Tgfbr2^Flox/Flox Fate⁺ and Tgfbr2^Wt/Wt Fate⁺ mice (Supplementary Fig. 5h, i).

We then injected anti-CD3 mAb to induce a transient intestinal inflammation in the small intestine of these mice. Similar to what we observed by using the Il17a^Cre Il10^Flox/Flox mice, Tgfbr2^Flox/Flox Fate⁺ were more susceptible to intestinal inflammation compared to the relative control. The Tgfbr2^Flox/Flox Fate⁺ lost more weight and had a more severe intestinal pathology than control Tgfbr2^Wt/Wt Fate⁺ mice (Supplementary Fig. 6a, b). We then harvested the intestinal tissues and analysed the lymphocyte composition. We observed that both the frequency and the amount of IL-10⁺ T_H17 cells and T_R1^exTH17 cells from the intestines of Tgfbr2^Flox/Flox Fate⁺ mice were significantly lower than those from WT Fate⁺ mice (Fig. 4c–e). Of note, similar to what is seen under steady state conditions, we did not observe statistically significant changes in the expression of Foxp3 among R26^YFP+ CD4⁺ T, nor did we observe differences in the number of Foxp3⁺ R26^YFP+ cells between the Tgfbr2^Flox/Flox Fate⁺ and Tgfbr2^Wt/Wt Fate⁺ mice (Supplementary Fig. 6c, d).

To exclude the possibility that reduced IL-10 production from the CD4⁺ YFP⁺ cells of Tgfbr2^Flox/Flox Fate⁺ mice was a consequence of more severe inflammation, we co-transferred CD4⁺ T cells from both CD45.2 Tgfbr2^Flox/Flox Fate⁺ mice and CD45.1/2 Tgfbr2^Wt/Wt Fate⁺ mice into Rag1^−/− mice. After we engrafted the cells, we injected anti-CD3 mAb and finally harvested the cells. We found that even when the cells resided in the same environment, Tgfbr2-deficient T_H17 cells lost their ability to express IL-10 compared to wild-type cells, which still produced IL-10 (Fig. 4f–h). We also observed that Tgfbr2-deficient R26^YFP+ T_H17 cells expanded and failed to preserve the expression of IL-17A (Supplementary Fig. 6e), suggesting a role of TGF-β signalling in controlling proliferation and IL-17A maintenance in this particular experimental setting. Taken together, these data indicate that mature T_H17 cells intrinsically require signalling via TGF-βRII to promote the expression of IL-10 in vitro and in vivo.

TGF-β signals via Smad3/4 to regulate IL-10 in T_H17 cells

The next step was to explore the signalling pathway that drives IL-10 expression upon TGF-β engagement with its receptor on mature T_H17 cells. After TGF-β engages its receptor, Smad2 and Smad3 complex is phosphorylated and by binding to either TIF1-γ or Smad4, translocates into the nucleus to activate gene expression²¹. Whether either Smad4 or TIF1-γ controls TGF-β-mediated IL-10 expression in mature T_H17 cells remained to be tested.

We first examined the role of TIF1-γ in the expression of IL-10 in T_H17 cells. To this end, we made Tif1g^Flox/Flox Fate⁺ mice, which similar to the Tgfbr2^Flox/Flox Fate⁺ mice described above, in order to specifically deplete Tif1g in Il17a producing cells (Supplementary Fig. 7a). After inducing intestinal inflammation in these mice, we observed that both IL-10⁺ T_H17 cells and T_R1^exTH17 cells remain comparable between Tif1g^Flox/Flox Fate⁺ mice and their wild-type littermate controls, suggesting that TIF1-γ is not required for IL-10 production in T_H17 cells in vivo (Supplementary Fig. 7b–d).

We then evaluated whether Smad4 is important for TGF-β-mediated IL-10 expression. To address this, we first created Smad4^Flox/Flox Fate⁺ mice in order to delete Smad4 in T_H17 cells (Supplementary Fig. 8a). Smad4-deficient CD4⁺ T cells had a slight, but significant impairment in IL-10 production when cultured under T_H17 conditions in vitro (Supplementary Fig. 8b, c). These mice were then injected with anti-CD3 mAb and IL-10⁺ T_H17 and T_R1^exTH17 cell populations were analysed. In line with the in vitro observations, both types of cells were reduced in the small intestines of Smad4^Flox/Flox Fate⁺ mice compared with the wild-type control mice (Fig. 5a–c).

**Fig. 5: TGF-β signals via Smad3/4 to regulate IL-10 in T_H17 cells.**

Finally, we also determined the role of Smad3 in regulating IL-10 production in T_H17 cells. We disrupted the function of Smad3 by using either Crispr/Cas9 mediated gene depletion (Fig. 5d, e), or small chemical inhibitor SIS3 in in vitro differentiated T_H17 cells (Supplementary Fig. 9a, b). In both cases, we observed that the induction of IL-10 in in vitro differentiated T_H17 cells by TGF-β was impaired when Smad3 was deleted/blocked. These data suggest that Smad3 is also required for TGF-β induced IL-10 production in T_H17 cells in vitro.

Taken together, these data show that while TIF1-γ is dispensable, Smad4 and Smad3 are necessary for TGF-β mediated IL-10 induction in mature T_H17 cells.

Smad3 and Smad4 activate Il10 transcription in T_H17 cells

We next sought to test whether Smad3 and Smad4 bind to the Il10 promoter in mature T_H17 cells. First, we tested whether phospho-Smad3 translocates into the nucleus shortly after TGF-β stimulation. Nuclear extracts of T_H17 cells were immunoblotted and we observed phospho-Smad3 in the nuclei of these cells (Fig. 6a). Next, we tested whether Smad3 and Smad4 are able to induce Il10 gene transcription. We first cloned Il10 proximal promoter (−1444 to +1) in the pGL2 vector upstream of Luciferase reporter gene, and Smad3 and Smad4 genes in pCMV and pCMVβ mammalian expression vectors respectively. Co-transfection of Il10 proximal promoter with increasing concentrations of either only Smad3 or only Smad4 expression plasmids did not result in significant upregulation of luciferase activity. However, when increasing concentrations of Smad4 plasmid were co-transfected with a constant amount of Smad3 plasmid, a significant increase in Il10-luciferase activity was observed (Fig. 6b). These data suggest that Smad3 and Smad4 synergistically activate the Il10 promoter.

In order to show that Smad3 and Smad4 directly bind the Il10 promoter in mature T_H17 cells, we performed Chromatin Immunoprecipitation (ChIP) experiments with FACS sorted T_H17 cells stimulated with or without TGF-β for 30 min. We found that 30 min after TGF-β treatment, both Smad3 and Smad4 accessed and bound the Il10 promoter on the −929/−756 element. Of note, between −929/−756 and −286/−283 base pairs on Il10 promoter lie predicted Smad3/4 binding sites (Fig. 6c). As a negative control, we interrogated the GAPDH TATA box promoter region where Smad3 and Smad4 proteins do not bind, and as expected we did not see any signal. Finally, in order to show that Smad3 and Smad4 proteins form a complex in T_H17 cells, we performed Proximity Ligation Assay (PLA) in FACS sorted T_H17 challenged for 30 min with TGF-β, using a plus and a minus ligation probe specific for anti-mouse Smad3 and anti-rabbit Smad4 antibodies, respectively. Confocal microscopic images reveal that the Smad3/4 complexes are only visible in the nucleus of T_H17 cells challenged with TGF-β (Fig. 6d). Interestingly, this protein complex forms 3–5 bright, closely spaced foci per cell. The PLA spots were located in the rim of the T_H17 cell nucleus associated with the nuclear membrane. Taken together, these results show that Smad3 and Smad4 proteins are instructed by TGF-β signal, form a nuclear complex that bind to the proximal Il10 promoter and transactivates Il10 transcription in T_H17 cells.

TGF-β promotes IL-10 expression in human T_H17 cells

We tested whether human T_H17 cells isolated from the intestine can also produce IL-10. We observed that a small but consistent frequency of CD4⁺ T cells isolated from healthy colon tissues from 14 human donors, co-produce IL-17A and IL-10 (Fig. 7a). Next, we wondered whether human T_H17 cells can also acquire the expression of IL-10 when stimulated with TGF-β. We therefore isolated circulating CD45RA^low CD25⁻ IL-17A⁺ (T_H17) cells from human blood using the IL-17A secretion assay and cultured the isolated T_H17 cells in the presence of increasing TGF-β concentrations. The purity of the T_H17 cells isolated from human blood was always more than 95% (for a representative purity plot see Supplementary Fig. 10a). Upon examining the CD4⁺Foxp3⁻ T cell compartment (see Supplementary Fig. 10b for the gating strategy), we observed that approximately half of the sorted cells, that were formerly IL-17A⁺, ceased to produce IL-17A (i.e. they become exT_H17 cells) while the other half retained IL-17A expression. However, this phenomenon was not affected by TGF-β (Fig. 7b). In contrast, TGF-β promoted IL-10 expression in both T_H17 cells and exT_H17 cells in a concentration-dependent manner (Fig. 7b). Finally, increasing TGF-β concentrations appeared to slightly reduce the frequency and the numbers of IL17A⁺ IFN-γ⁺ and IFN-γ⁺ producing cells (Supplementary Fig. 10c, d). Furthermore, increasing the TGF-β concentrations did not have a reproducible effect on Foxp3 expression in human peripheral blood-isolated T_H17 cells (Supplementary Fig. 10e). Collectively, these results show that human T_H17 cells from the intestine and from peripheral blood, are able to produce IL-10 and furthermore, that TGF-β is able to promote dose dependent IL-10 expression in human peripheral blood derived T_H17 cells.

Discussion

T_H17 cells are usually found in the inflamed tissues of IMID patients such as the central nervous system, the kidney, the joints and the heart. However, they are also abundant in the small intestine of healthy individuals without causing any overt diseases^30,31,32. The T_H17 cell plastic behaviour allowing them to acquire both pro- and anti-inflammatory fate can explain such ubiquitous presence and consequences: pathological or physiological. Our data show that it is in fact mainly in the ileum and Peyer’s patches of mice where these cells acquire their anti-inflammatory fate. This suggests that continuous plasticity from T_H17 cells to IL-10 producing T_H17 cells and possibly to T_R1^exTH17 cells impairs the pathogenic immune reaction of effector T_H17 cells in the intestinal tract. Supporting this, when T_H17 cell-derived IL-10 is lacking, the cellular and molecular immune homeostasis of the intestine is disturbed, showing the relevance of the anti-inflammatory fate of these cells. This effect is remarkable considering that only a relatively small fraction of T_H17 cells acquire an anti-inflammatory function. Finally, our data show that also human T_H17 cells acquire the regulatory phenotype when exposed to TGF-β1.

Despite the above, we did not observe macroscopic tissue damage in the Il17a^Cre Il10^Flox/Flox mice. One explanation is the compensatory mechanism which could be exerted by the presence of other regulatory T cells, such as Foxp3⁺ Treg cells and T_R1 cells able to produce IL-10^23,25. Indeed, it has to be considered that only a fraction of T_R1 cells originate from the T_H17 cells, while the rest originate from other cells, including probably T_H1 cells³³. Thus, the latter T_R1 cell fraction is still functional in this mouse model. Another explanation is the composition of the intestinal microbiota of our mice. It is possible that under different specific pathogen free conditions, also Il17a^Cre Il10^Flox/Flox mice develop microscopically evident intestinal inflammation.

Interestingly, we observed a specific expansion of intestinal T_H17 and T_H1/T_H17 cells, but not of T_H1 cells in our Il17a^Cre Il10^Flox/Flox mouse model. One possible explanation of this cell-selective control mediated by IL-10 is that both T_H17 and T_H1/ T_H17 cells express higher level of IL-10R compared to T_H1 cells. Alternatively, one could consider that this is due to a dysregulation of Rorgt⁺ Foxp3⁺ Treg cells in Il17a^Cre Il10^Flox/Flox. These cells are indeed known to be able to specifically regulate T_H17 cells, especially in the colon³⁴. However, only a small fraction of Il17a^Cre-activated cells are Foxp3⁺ and the large majority of Rorgt⁺ Foxp3⁺ Treg cells are known to express little to no IL-17A and thus are not mainly affected in the small intestine of the Il17a^Cre Il10^Flox/Flox mice^35,36. Therefore, these data suggest that a possible dysregulation of Rorgt⁺ Foxp3⁺ Treg cells is not the explanation for the selective increases in the number of T_H17 cells observed in this study.

T_H17 cells also play a key role in mediating host defence against bacteria¹. Through evolution, pathogens have developed mechanisms to evade the immune system of the host. For example, it was shown in mice and humans that S. aureus, a nosocomial and potentially multi drug resistant bacteria, promotes the anti-inflammatory fate of T_H17 cells^7,26. Our data add to this because they show that the T_H17 cell anti-inflammatory fate can indeed favour dissemination of the pathogens. Given that this anti-inflammatory fate has been preserved throughout evolution, we wondered what its benefit is, and at what cost it comes. Considering that S. aureus bacteria only becomes a lethal threat when it disseminates through the blood stream, we propose that the benefit is the T_H17 cell anti-inflammatory fate’s ability to constantly maintain the immune homeostasis. We also propose that the cost of the T_H17 cell anti-inflammatory fate is rather low, considering that occurrence of a bacterial infection through the blood is relatively unlikely.

The role of TGF-β during the differentiation of T_H17 cells has been widely studied and also debated^9,37. It is currently accepted that TGF-β is sufficient, but not necessary for the induction of these cells and in addition, that it favours the development of T_H17 with regulatory potential. Our experiments aimed to expand the understanding of TGF-β function from the early differentiation phase to the effector phase of T_H17 cell biology. We showed for the first time directly in vivo that Tgfbr2-deficient T_H17 cells had an impaired capacity to produce IL-10. In addition, the Tgfbr2^Flox/Flox Fate⁺ mice phenocopied the impairment in immune regulation observed in the Il17a^Cre Il10^Flox/Flox mice. These results broaden the state of knowledge of TGF-β, revealing the role of TGF-β in plasticity and function of T_H17 cells upon maturation.

Furthermore, we noticed that under steady state conditions and after anti-CD3 mAb treatment, the frequency of YFP⁺ cells increase when TGF-βRII signalling is impaired. This suggests that the expansion of T_H17 cells, which could otherwise lead to pathogenicity, is controlled by TGF-β. This is in line with the known anti-proliferative effect of TGF-β on CD4⁺ T cells³⁸. Furthermore, we observed that the large majority of TGF-βRII deficient YFP⁺ cells lose the expression of IL-17A under steady state conditions and upon transfer into Rag1^−/− mice, while they maintain the expression of IL-17A during intestinal inflammation. On the one hand, this is in keeping with the concept of a “sufficient but not necessary” role of TGF-β during the differentiation of T_H17 cells: under certain conditions, TGF-β is necessary to maintain IL-17A expression, but during inflammation it becomes unnecessary. On the other hand, this also suggests that the fraction of T_H17 cells which do lose IL-17A, but express IL-10 in wild type mice during inflammation have restrained the TGF-β signalling towards Smad3/Il10 thus avoiding the re-activation of RORγt/IL-17A pathway. It has indeed been shown that TGF-β blocks RORγt activity via Smad3¹⁹ and that TGF-β can restrain IL-17A by a post-translational deubiquitination of RORγt²⁸.

Of note, TGF-β appears to impact IL-10 production also in other effector CD4⁺ T cells such as T_H1 cells, although the current evidence is controversial. For example, TGF-β has been shown to inhibit IL-10 production in T_H1 cells by blocking the expression of Blimp-1³⁹, while others reported a positive effect of TGF-β on IL-10 production by T_H1 cells^40,41. Therefore, TGF-β seems to have different effects on T_H1 and T_H17 cells regarding IL-10 production, but further in vivo studies on T_H1 cells are required to confirm this.

Downstream of TGF-β receptor, our results suggest that the canonical TGF-β mediators Smad3 and Smad4—but not TIF1-γ—promote the expression of IL-10 in mature T_H17 cells. Apparently in contrast to our data, it has been shown that TIF1-γ blocks the expression of IL-10 in CD4⁺ T cells while differentiating into T_H17 cells²². However, while this study used the CD4^Cre Tif1g^Flox/Flox mouse model, we used an Il17A^Cre Tif1g^Flox/Flox mouse model instead. One possible explanation is that during T_H17 cell differentiation, TIF1-γ constrains IL-10 expression by obstructing Smad-recognized cis-elements from the Smad4-Smad2/3 complexes, and that this becomes dispensable in mature T_H17 cells when the Il10 gene is already accessible. In keeping with the different function of TIF1-γ in the two different phases, this is also evident regarding the regulation of IL-17A expression: TIF1-γ plays a key role in the expression of IL-17A during T_H17 cell differentiation²². However, our data suggest that its deletion in mature T_H17 cells becomes dispensable for IL-17A expression. Therefore, these datasets are -probably- not incompatible with each other, but rather they reveal different molecular mechanisms operating during the differentiation and maturation phases of T_H17 cells.

Cell clones of blood derived human T_H17 cells are capable of acquiring the expression of IL-10 in vitro²⁶. In line with this data, here we show that human primary T_H17 cells are also able to produce IL-10 and are present in the human intestine. It has recently been suggested that IL-27 promotes the expression of IL-10, via the transcription factor c-Maf, in human T_H17 clones¹⁶. However, whether IL-27 alone or in combination with TGF-β can also induce the expression of IL-10 in freshly isolated human T_H17 cells remains to be tested. Nevertheless, our data serve as proof of principle to show that it is possible to turn freshly isolated human T_H17 cells into IL-10 producer cells.

The transcription factor Blimp1 has also been proposed as being able to promote the conversion of T_H17 cells into T_R1 cells¹⁴. However, it is also known that TGF-β blocks Blimp1 activation^39,42. Because of this, we did not investigate the role of Blimp1 in our system. However, our data do not exclude a role of Blimp1 in the anti-inflammatory fate of T_H17 cells and it could be possible that TGF-β and IL-27 are two complementary pathways to induce the conversion of T_H17 cells into T_R1 cells in different microenvironments.

Collectively, our data show that the anti-inflammatory fate of T_H17 cells is not a mere consequence of immune homeostasis, but that it actually plays an indispensable role in the maintenance of this equilibrium. TGF-β mediates the expression of IL-10 via Smad3 and Smad4 and consequently, it is the fundamental environmental signal to tighten the balance between the pro- and anti-inflammatory fates of mature T_H17 cells. We propose that the T_H17 cell plasticity between pro and anti-inflammatory fates is a key feature of immune system adaptation and when impaired, immunity and tissue integrity are compromised. Exploring the molecular mechanisms of this biological phenomena will help to identify therapeutic targets, such as Smad3 and Smad4 for new therapies that aim to steer the immune response according to the clinical need, rather than globally suppress it, as the majority of the current therapies have been based upon.

Methods

Mice

C57BL/6 Rag1^−/− mice (Stock #: 002216) and Rosa26-Cas9 knock-in mice (Stock #: 028555) were purchased from the Jackson Laboratories. Il10^Flox/Flox mice (kindly provided by Axel Roers) were further crossed with Il17A^Cre mice (kindly provided by Dr. Brigitta Stockinger). Tgfbr2^Flox/Flox (purchased from JAX, Stock #: 012603), Smad4^Flox/Flox (kindly provided Dr. Elizabeth Robertson⁴³) and Tif1g^Flox/Flox (kindly provided by Dr. Vesa Kaartinen⁴⁴) mice were further crossed with Fate⁺ mice (Foxp3^RFP, Il10^eGFP, Il17A^CRE/Katushka, R26^YFP, as described before⁷) to generate Tgfbr2^Flox/Flox Fate⁺ (Tgfbr2^Flox/Flox, Foxp3^RFP, Il10^eGFP, Il17A^CRE/Katushka, R26^YFP), Smad4 ^Flox/Flox Fate⁺ (Smad4^Flox/Flox, Foxp3^RFP, Il10^eGFP, Il17A^CRE/Katushka, R26^YFP) and Tif1g ^Flox/Flox Fate⁺ (Tif1g^Flox/Flox, Foxp3^RFP, Il10^eGFP, Il17A^CRE/Katushka, R26^YFP) mice. In these models, cells expressing a high level of Il17a activate the CRE recombinase to delete the stop sequence 5′ to YFP and to deplete Tgfbr2, Smad4 or Tif1g. Thus, such IL-17A-expressing cells are permanently marked by YFP and in the meantime, lose the expression of Tgfbr2, Smad4 or Tif1g genes. All mice were kept under specific pathogen-free (SPF) conditions, on a 12/12 on/off light cycle, maintained at 72 (+/−2) °F with 70% humidity in the animal facility at Yale University. Age- and sex-matched littermates between 8 to 24 weeks of age were used for experiments. Unless they came with special instructions, mice were randomly assigned to different experimental groups and each cage contained animals of all different experimental groups. Both male and female mice were used in experiments. Animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of Yale University. Preliminary experiments were tested to determine sample sizes, taking available recourses and ethical use into account.

Anti-CD3 mAb treatment and intestinal histology

Anti-CD3 mAb (Clone #: 2C11) were injected intra-peritoneally three times (15, 15, and 30 μg per mouse) every other day. Mice were euthanised with CO₂ 24 h after the last injection. Different parts of small intestines (duodenum, jejunum and ileum) were fixed in Bouin’s Fixative Solutions for 1 h. Tissues were then embedded in paraffin for sectioning. Pictures were taken by optical microscope equipped with camera systems and analysed.

Lymphocyte isolation from mouse small intestine

Methods were described before in detail⁴⁵. Basically, intestinal tissues were first digested in 1 mM DTE at 37 °C for 30 min to get the IEL fraction. Remaining tissues were then digested in 1 mg/ml collagenase from Clostridium Histolyticum at 37 °C for another 30 min to get the LPL fraction. Both fractions were further applied with Percol gradient centrifugation to enrich lymphocyte populations.

Flow cytometry antibodies and intracellular cytokine staining

Mouse T cells were stained with monoclonal antibodies to CD4 (GK1.5, Cat # 100428 or RM4-5 Cat # 100536), CD8 (53-6.7 Cat # 100722), NK1.1 (PK136 Cat # 108713), CD19 (6D5 Cat # 115508), CD11b (M1/70 Cat # 101216), CD11c (N418 Cat # 117318), γδTCR (GL3 Cat # 118123), TGFβRII (R&D Systems Cat # FAB532P). All antibodies without further instructions are purchased from eBiolegend and diluted 1:200 for staining at 4 °C. Importantly, TGFβRII staining was performed at 37 °C for 30 min with 1:50 dilution. Although in the figure legends we referred only to CD4⁺ T cells, in each FACS related experiment we specifically analysed CD4⁺ T cells CD8⁻, NK1.1⁻, CD19⁻, CD11b⁻, CD11c⁻, γδTCR⁻. For intracellular cytokine staining, the cells were re-stimulated for 3 h at 37 °C with phorbol 12-myristate 13-acetate (PMA) (Sigma, 50 ng ml⁻¹) and ionomycin (Sigma, 1 μg ml⁻¹) in the presence of Golgistop (BD Bioscience). Cells were then fixed in 3.7% formaldehyde for 20 min at room temperature. After washing, the cells were then permeabilized in 0.1% NP40 and stained at 37 °C with anti-IL-17A (TC11-18H10.1 Cat # 506925), anti-IFNγ (BD Bioscience, Cat # 554412) antibodies for 30 min with 1:200 dilution. Lymphocytes were re-suspended in PBS, 0.5% FBS, 5 mM EDTA and acquired with an LSRII cytometer (BD Bioscience).

Staphylococcus aureus infections

Heat-inactivated S. aureus (ATCC 14458, SEB+ TSST-1-) was injected intravenously (1 × 10⁷ colony forming units per mouse) into 4-week-old mice for immunization purposes. Three weeks later, the mice were injected intravenously again with 1 × 10⁶ live S. aureus bacteria. Mice were euthanised with CO₂ 1 week after the 2nd injection, when they displayed clinical symptoms of sepsis. Different organs were then harvested to examine the colony forming unit (CFU) of S. aureus. T cells isolated from intestines were further analyzed by FACS.

Plasmids and transfections

The coding sequences for Smad3 and Smad4 were cloned via reverse transcription and PCR from murine C57BL/6 splenic leukocytes total RNA with the appropriate primers, Superscript III reverse transcriptase (Invitrogen) and Phusion® Hot Start Flex DNA polymerase (New England Biolabs). The PCR products were cloned in pGEM®-T Easy vector (Promega) and were subsequently sub-cloned into pCMVT_NT™ (Promega) and pCMV-Tag2 (Agilent Technologies) mammalian expression vectors respectively, using the appropriate primers and the InFusion ligation system (Takara). The Il10 proximal promoter (from −1444 to +1 bp) was cloned via PCR from C57BL/6 genomic DNA with appropriate primers and was subcloned into pGL2 vector (Clontech) using the InFusion ligation system (Takara) and appropriate primer sets. Transfections were performed in HEK293T cells with the BES buffered saline/CaCl₂ method. Briefly, expression and reporter plasmid mixes were left to precipitate for 20 min at room temperature, in a solution containing 0.125 M CaCl₂, 0.025 M BES, 0.02 NaCl, 0.00075 NaH₂PO₄, pH:6.95. The precipitated plasmid mix was overlaid carefully on the HEK293T cell DMEM 10% FBS culture medium. In all, 24 h later the transfection medium was aspirated and fresh DMEM 10% FBS was placed onto the HEK293T cells. Cells were collected 48 h after transfection, washed twice with PBS and lysed in Passive Lysis Buffer (Promega). Luciferase activity was determined using the Luciferase Assay System (Promega) and was measured in a FluoStar Omega reader and Software. Transfection efficiency was determined by spiking all transfections with 0.5 ng pCMV-EGFP vector (Clontech) and measuring GFP activity in the lysates.

T_H17 cell differentiation and immunoblot

Briefly, naïve CD4⁺ T cells were isolated from the spleen and lymph nodes of 4–6 mice of the indicated transgenic mouse strains with the mouse naïve CD4⁺ T cell isolation Kit (Stemcell). The cells were cultured for five days under T_H17 polarizing conditions, in Click’s medium supplemented with 5% FBS, 0,1 mM β-merkaptoethanol, Glutamax™ (Gibco), 100 U/mL Penicillin/Streptomycin, 10 μg/mL anti-CD3, 2 μg/mL anti-CD28, 10 μg/mL anti-IFNγ, 10 μg/mL anti-IL-4, 20 ng/mL murine IL-23, 20 ng/mL murine IL-6, 0.5 ng/mL murine TGF-β1 (unless specially indicated). T_H17 cells were sorted based on the IL-17A reporter expression resuspended into 2 × 10⁶ cells/mL and then challenged with or without TGF-β for 30′ min. Subsequently the cells were lysed and either total or nuclear extracts were obtained and loaded on 4–15% precast acrylamide gels (Mini-PROTEAN, BIO-RAD). After electrophoresis the proteins were transferred to PVDF membranes. The membranes were immunoblotted with the indicated antibodies and developed according to standard protocols. We loaded the protein extract equivalent corresponding to 8 × 10⁵ T_H17 cells in each well.

Retroviral preparation and transduction

For retroviral preparation, 1 μg of individual Smad3 sgRNA vector with 0.5 μg of EcoHelp plasmid were employed to transfect HEK293T cells. In all, 12 h later, media was replaced and virus was grown for another 48 h. Supernatant containing virus was collected and polybrene was added to achieve a final concentration of 4 μg/ml. For retroviral transduction, Cas9-expressing T cells were first activated for 24 h and then spin transduced with viral supernatant.

Chromatin Immunoprecipitation

Rested T_H17 cells were challenged or not with 1 μg/mL TGF-β1 for 30 min. The cells were fixed with 1.1% Formaldehyde for 10 min, washed, and re-suspended in 10 mM Tris pH:7.5, 10 mM NaCl, 3 mM MgCl₂, 1 mM CaCl₂, 4% NP40 supplemented with protease inhibitors, at a final concentration of 4 × 10⁷ cells/mL. Subsequently, 0.2 units MNase (Sigma) were added for 5 min at 37 °C, followed by 3 mM EGTA and the cells were centrifuged at 500 g and re-suspended in 50 mM Hepes pH:7.9, 150 mM NaCl, 5 mM EDTA, 0.5 mM EGTA, 0.1%SDS, 0.1% Na-deoxycholate, supplemented with protease inhibitors and sonicated 3 times for 20 sec. 1% Triton X-100 was added and the samples were centrifuged for 15000 g for 15 min at 4 °C. The lysates were extensively dialysed in 10 mM Tris pH: 7.5, 5% glycerol, 1 mM EDTA, 0.5 mM EGTA. For immunoprecipitation, T_H17 cell lysates were incubated o/n with designated antibodies and the next day were mixed with Dynabeads™ Protein G (Invitrogen, #00374128) in RIPA buffer for 4 h at 4 °C. The beads were washed in low (150 mM NaCl), high (500 mM NaCl) and LiCl (250 mM) salt buffer, the crosslinks were reversed at 65 °C, the samples were purified by Phenol/Chlorophorm extraction, the DNA was precipitated and used in q-PCR reactions.

Real-time quantitative PCR

qPCR was performed using chromatin immunoprecipitation reactions with the anti-Smad3 and Smad4 and isotype control antibodies, along with the indicated primers and KAPA SYBR FAST qPCR Kit (Kapa Biosystems, Wilmington, MA) in a StepOne cycler (Applied Biosystems, Carlsbad, CA). The CT values from triplicate qPCR reactions were extracted from the StepOne cycler (Applied Biosystems, Carlsbad, CA) onto spreadsheets and were analyzed with the relative quantification method 2^–ΔΔCT. The abundance level of a given amplicon per sample/condition was determined relative to its input (non-enriched) chromatin abundance and was additionally corrected relative to isotype control antibody immunoprecipitation sample.

Proximity ligation assay

In vitro differentiated sorted T_H17 cells were rested for 5 days in Click’s medium supplemented with 2 ng/mL murine IL-2 (PeproTech #212-12) and were subsequently challenged with 1 μg/mL human TGF-β1 for 30 min. Subsequently, the cells were washed, re-suspended in a minimal volume of PBS supplemented with 10% FBS 0.3% BSA, overlaid onto coverslips and were left to dry for 12 h. The cells were rehydrated with PBS, fixed with 4%PFA and permeabilized with 0.3% PBS-Triton X100. After washing, the specimens were blocked, incubated with pospho-Smad3 and Smad4 antibodies and stained with Duolink® In Situ detection Reagents Red (Sigma). After mounting, the slides were analysed by confocal microscopy and the acquired images were opened and processed with Fiji software (Image J).

Lymphocyte isolation from human intestine

The human colonic tissue is derived from colon cancer patients admitted into the UKE General Surgery Clinic. The study was approved by the Ethical Physicians Committee of Hamburg (Ethik-Kommision der Aertztekammer Hamburg) and Informed Written Consent was obtained from each one of the sample donors. The general characteristics of the participants cohort were five males and nine females with an average age of 69,5 years (±SD = 11 y) Healthy tissues adjacent to the tumor, were collected by collaborating surgical personnel, immediately after the completion of the surgical procedure. Next, the tissue samples were processed for lymphocyte isolation. Intraepithelial lymphocytes were isolated by digesting the tissue with Dithiothreitol (DTT Sigma-Aldrich) solution at 37 °C for 20 min, followed by incubation with collagenase IV (100 U; Sigma-Aldrich) for 30 min at 37 °C. The cells were further separated by a Percoll gradient (GE Healthcare). After this the cells were stained for FACS analysis. Only the healthy colonic tissue data analysis with respect to CD4⁺FOXP3⁻IL17A⁺ and IL-10⁺ cell compartment is presented in this manuscript. For a comprehensive description of the patients, please refer to the Source data file of Supplementary Fig. 9e. Part of the human cohort analyzed in this study was also used for assessing the expression of IL-22 in Perez et al.⁴⁶.

Sorting of humanT_H17 cells from Buffy Coat

Enriched human Buffy Coat samples retrieved directly from the UKE Transfusion Medicine, were diluted with PBS to a total volume of 350 mL. The diluted blood samples were overlaid to buffered Biocoll separating solution (Merck, #L6715) and centrifuged at 300 g for 20 min. The PBMCs were collected, washed with PBS and stimulated for 3 h with 50 ng/mL PMA and 1μΜ Ionomycin. CD4⁺ T cells were selected with magnetic human CD4 microbeads (#130-045-101, Miltenyi, Bergisch-Gladbach, Germany). IL-17⁺ cells were stained with the IL17A secretion assay detection kit (#130-094-537, Miltenyi, Bergisch-Gladbach Germany) and with human anti-CD4/FITC, anti-CD45RA/Alexa700, anti-CD127/PE.Cy7 and anti-CD25/BV650 and sorted with an Aria Illusion instrument (BD Bioscience). In all, 5–8 × 10³ sorted CD4⁺ IL-17A⁺ CD45RA⁻CD127⁻CD25⁻ cells were rested in RPMI medium (supplemented with 10% FBS, 10 mM β-merkaptoethanol, Glutamax, Penicillin/Streptomycin 100 U/mL) plus 2 ng/mL IL-2 (PeproTech). After 48 h the cells were challenged with increasing concentrations of TGF-β1 for five days. Subsequently, cells were stimulated with PMA/Ionomycin, stained for CD4, IL-17A, and IL-10 expression and analysed by FACS.

Statistics

FACS data were visualized and analyzed with FlowJo 10.5.3 (BD Bioscience). Statistical analyses were calculated in Prism (Graphpad Software). According to the experimental set-up we used Mann–Whitney U test or Welch’s t-test (Data specified in Figs. 1–5), two-way ANOVA (Fig. 6b) and χ² test (Fig. 6d). The p values presented in Fig. 7 were calculated via the Mann–Whitney U test. The specific statistical analyses used in each figure are further described in the figure legends. When not otherwise specified, the statistical test used is always two-sided. p < 0.05 was considered significant.

Reporting summary

Further information on research design is available in the Nature Research Reporting Summary linked to this article.

Data availability

We declare that the data supporting the findings of this study are available within the paper (and its Supplementary Information files). Source data are provided with this paper.

References

Curtis, M. M. & Way, S. S. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126, 177–185 (2009).
CAS PubMed PubMed Central Google Scholar
Zhang, S. et al. Reversing SKI-SMAD4-mediated suppression is essential for TH17 cell differentiation. Nature 551, 105–109 (2017).
ADS PubMed PubMed Central Google Scholar
Puel, A. et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332, 65–68 (2011).
ADS CAS PubMed PubMed Central Google Scholar
Holland, S. M. et al. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med 357, 1608–1619 (2007).
CAS PubMed Google Scholar
Zhang, Q. et al. Combined immunodeficiency associated with DOCK8 mutations. N. Engl. J. Med. 361, 2046–2055 (2009).
CAS PubMed PubMed Central Google Scholar
Esplugues, E. et al. Control of TH17 cells occurs in the small intestine. Nature 475, 514–518 (2011).
CAS PubMed PubMed Central Google Scholar
Gagliani, N. et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523, 221–225 (2015).
ADS CAS PubMed PubMed Central Google Scholar
Omenetti, S. et al. The intestine harbors functionally distinct homeostatic tissue-resident and inflammatory Th17 Cells. Immunity 51, 77–89 e76 (2019).
CAS PubMed PubMed Central Google Scholar
Mangan, P. R. et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441, 231–234 (2006).
ADS CAS PubMed Google Scholar
Zhou, L. et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8, 967–974 (2007).
CAS PubMed Google Scholar
Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A. & Sallusto, F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8, 942–949 (2007).
CAS PubMed Google Scholar
Wilson, N. J. et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8, 950–957 (2007).
CAS PubMed Google Scholar
Xu, J. et al. c-Maf regulates IL-10 expression during Th17 polarization. J. Immunol. 182, 6226–6236 (2009).
CAS PubMed PubMed Central Google Scholar
Chang, K. K. et al. IL-27 triggers IL-10 production in Th17 cells via a c-Maf/RORgammat/Blimp-1 signal to promote the progression of endometriosis. Cell Death Dis. 8, e2666 (2017).
CAS PubMed PubMed Central Google Scholar
Gabrysova, L. et al. c-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4(+) T cells. Nat. Immunol. 19, 497–507 (2018).
CAS PubMed PubMed Central Google Scholar
Aschenbrenner, D. et al. An immunoregulatory and tissue-residency program modulated by c-MAF in human TH17 cells. Nat. Immunol. 19, 1126–1136 (2018).
CAS PubMed PubMed Central Google Scholar
McGeachy, M. J. et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8, 1390–1397 (2007).
CAS PubMed Google Scholar
Martinez, G. J. et al. Smad2 positively regulates the generation of Th17 cells. The. J. Biol. Chem. 285, 29039–29043 (2010).
CAS PubMed PubMed Central Google Scholar
Martinez, G. J. et al. Smad3 differentially regulates the induction of regulatory and inflammatory T cell differentiation. J. Biol. Chem. 284, 35283–35286 (2009).
CAS PubMed PubMed Central Google Scholar
Xi, Q. et al. A poised chromatin platform for TGF-beta access to master regulators. Cell 147, 1511–1524 (2011).
CAS PubMed PubMed Central Google Scholar
He, W. et al. Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell 125, 929–941 (2006).
CAS PubMed Google Scholar
Tanaka, S. et al. Trim33 mediates the proinflammatory function of Th17 cells. J. Exp. Med 215, 1853–1868 (2018).
CAS PubMed PubMed Central Google Scholar
Uhlig, H. H. et al. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J. Immunol. 177, 5852–5860 (2006).
CAS PubMed PubMed Central Google Scholar
Round, J. L. & Mazmanian, S. K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl Acad. Sci. USA 107, 12204–12209 (2010).
ADS CAS PubMed Google Scholar
Huber, S. et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3(−) and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 34, 554–565 (2011).
CAS PubMed PubMed Central Google Scholar
Zielinski, C. E. et al. Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 484, 514–518 (2012).
ADS CAS PubMed Google Scholar
Chatenoud, L. & Bluestone, J. A. CD3-specific antibodies: a portal to the treatment of autoimmunity. Nat. Rev. Immunol. 7, 622–632 (2007).
CAS PubMed Google Scholar
Rutz, S. et al. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells. Nature 518, 417–421 (2015).
ADS CAS PubMed Google Scholar
Karmaus, P. W. F. et al. Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity. Nature 565, 101–105 (2019).
ADS CAS PubMed Google Scholar
Weaver, C. T., Elson, C. O., Fouser, L. A. & Kolls, J. K. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu. Rev. Pathol. 8, 477–512 (2013).
CAS PubMed Google Scholar
Turner, J. E., Paust, H. J., Steinmetz, O. M. & Panzer, U. The Th17 immune response in renal inflammation. Kidney Int. 77, 1070–1075 (2010).
CAS PubMed Google Scholar
Tesmer, L. A., Lundy, S. K., Sarkar, S. & Fox, D. A. Th17 cells in human disease. Immunol. Rev. 223, 87–113 (2008).
CAS PubMed PubMed Central Google Scholar
Roncarolo, M. G., Gregori, S., Bacchetta, R., Battaglia, M. & Gagliani, N. The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases. Immunity 49, 1004–1019 (2018).
CAS PubMed Google Scholar
Yang, B. H. et al. Foxp3(+) T cells expressing RORgammat represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation. Mucosal Immunol. 9, 444–457 (2016).
CAS PubMed Google Scholar
Sefik, E. et al. MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORgamma(+) regulatory T cells. Science 349, 993–997 (2015).
ADS CAS PubMed PubMed Central Google Scholar
Lochner, M. et al. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J. Exp. Med. 205, 1381–1393 (2008).
CAS PubMed PubMed Central Google Scholar
Ghoreschi, K. et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 467, 967–971 (2010).
ADS CAS PubMed PubMed Central Google Scholar
Delisle, J. S. et al. The TGF-beta-Smad3 pathway inhibits CD28-dependent cell growth and proliferation of CD4 T cells. Genes Immun. 14, 115–126 (2013).
CAS PubMed Google Scholar
Neumann, C. et al. Role of Blimp-1 in programing Th effector cells into IL-10 producers. J. Exp. Med 211, 1807–1819 (2014).
CAS PubMed PubMed Central Google Scholar
Huss, D. J. et al. TGF-beta signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE. Eur. J. Immunol. 41, 2987–2996 (2011).
CAS PubMed PubMed Central Google Scholar
Huss, D. J. et al. TGF-beta enhances effector Th1 cell activation but promotes self-regulation via IL-10. J. Immunol. 184, 5628–5636 (2010).
CAS PubMed PubMed Central Google Scholar
Salehi, S. et al. B lymphocyte-induced maturation protein-1 contributes to intestinal mucosa homeostasis by limiting the number of IL-17-producing CD4+ T cells. J. Immunol. 189, 5682–5693 (2012).
CAS PubMed PubMed Central Google Scholar
Chu, G. C., Dunn, N. R., Anderson, D. C., Oxburgh, L. & Robertson, E. J. Differential requirements for Smad4 in TGFbeta-dependent patterning of the early mouse embryo. Development 131, 3501–3512 (2004).
CAS PubMed Google Scholar
Kim, J. & Kaartinen, V. Generation of mice with a conditional allele for Trim33. Genesis 46, 329–333 (2008).
CAS PubMed PubMed Central Google Scholar
Lefrancois, L. & Lycke, N. Isolation of mouse small intestinal intraepithelial lymphocytes, Peyer’s patch, and lamina propria cells. Curr. Protoc. Immunol. https://doi.org/10.1002/0471142735.im0319s17 (2001).
Perez, L. G. et al. TGF-beta signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer. Nat. Commun. 11, 2608 (2020).
ADS CAS PubMed PubMed Central Google Scholar

Download references

Acknowledgements

This work was supported by European Research Council (ERC) (StG 715271 to N.G.) and Deutsche Forschungsgemeinschaft (DFG) (Project number335447717; SFB1328, Project A14 to N.G. and E.T.). This work was supported in part by grants provided by AbbVie (to R.A.F.). The authors thank Elaine Hussey for editing the manuscript. The authors thank Dr. Kristoffer Riecken and Prof. Dr. Boris Fehse in the Center of Oncology, Department of Stem Cell transplantation in UKE, Hamburg for the human HEK293T cells donation, Dr. Markus Heine and Prof. Dr. Joerg Heeren at the Center of Experimental Medicine, Institute of Biochemistry and Molecular cell Biology, UKE Hamburg for their help with the confocal microscopy. Furthermore, the authors wish to thank the UKE, Hamburg Animal Models and Fluorescent Activation Cell sorting core facilities for excellent experimental support.

Author information

These authors contributed equally: Hao Xu, Theodora Agalioti.

Authors and Affiliations

Department of Immunobiology, School of Medicine, Yale University, New Haven, CT, 06520, USA
Hao Xu, Jun Zhao, Maria Carolina Amezcua Vesely, Piotr Bielecki, Ruaidhri Jackson & Richard A. Flavell
Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany
Theodora Agalioti, Ramez Wahib, Daniel Perez, Jakob Izbicki & Nicola Gagliani
I. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany
Babett Steglich, Samuel Huber & Nicola Gagliani
Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA
Will Bailis
Division of Protective Immunity, The Children’s Hospital of Philadelphia, Philadelphia, PA, 19104, USA
Will Bailis
Departamento de Biología Celular y del Desarrollo, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, D.F, México
Paula Licona-Limón
Biologic and Material Sciences, University of Michigan, 1011N. University Ave, Ann Arbor, MI, 48109, USA
Vesa Kaartinen
INGM-National Institute of Molecular Genetics “Romeo ed Enrica Invernizzi”, Milan, Italy
Jens Geginat
Department of Clinical Sciences and Community Health, Università degli studi di Milano, Milan, Italy
Jens Geginat
Laboratory of Molecular and Cellular Immunology, Principe Felipe Research Center (CIPF), 46012, Valencia, Spain
Enric Esplugues
Institute of Immunology, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany
Eva Tolosa
Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA
Richard A. Flavell
Immunology and Allergy Unit, Department of Medicine, Solna, Karolinska Institute and University Hospital, Stockholm, Sweden
Nicola Gagliani

Authors

Hao Xu
View author publications
You can also search for this author in PubMed Google Scholar
Theodora Agalioti
View author publications
You can also search for this author in PubMed Google Scholar
Jun Zhao
View author publications
You can also search for this author in PubMed Google Scholar
Babett Steglich
View author publications
You can also search for this author in PubMed Google Scholar
Ramez Wahib
View author publications
You can also search for this author in PubMed Google Scholar
Maria Carolina Amezcua Vesely
View author publications
You can also search for this author in PubMed Google Scholar
Piotr Bielecki
View author publications
You can also search for this author in PubMed Google Scholar
Will Bailis
View author publications
You can also search for this author in PubMed Google Scholar
Ruaidhri Jackson
View author publications
You can also search for this author in PubMed Google Scholar
Daniel Perez
View author publications
You can also search for this author in PubMed Google Scholar
Jakob Izbicki
View author publications
You can also search for this author in PubMed Google Scholar
Paula Licona-Limón
View author publications
You can also search for this author in PubMed Google Scholar
Vesa Kaartinen
View author publications
You can also search for this author in PubMed Google Scholar
Jens Geginat
View author publications
You can also search for this author in PubMed Google Scholar
Enric Esplugues
View author publications
You can also search for this author in PubMed Google Scholar
Eva Tolosa
View author publications
You can also search for this author in PubMed Google Scholar
Samuel Huber
View author publications
You can also search for this author in PubMed Google Scholar
Richard A. Flavell
View author publications
You can also search for this author in PubMed Google Scholar
Nicola Gagliani
View author publications
You can also search for this author in PubMed Google Scholar

Contributions

H.X., T.A., N.G., and R.A.F. designed the study and wrote the paper. H.X. and T.A. designed and performed experiments. R.W., D.P. and J.I. provided and analyzed the human colonic biopsies. W.B. assisted with the sgRNA silencing experiments. V.K. provided the Tif1g^Flox/Flox mouse. J.Z., B.S., M.C.A., P.B., R.J., J.G., P.L.L., and E.E. S.H. and discussed and interpreted the results. E.T. provided help with the human T_H17 cell culture and protocols. S.H. analyzed histological samples and interpreted the results. All authors edited and approved the paper.

Corresponding authors

Correspondence to Richard A. Flavell or Nicola Gagliani.

Ethics declarations

Competing interests

The authors declare no competing interest.

Additional information

Peer review information Nature Communications thanks Toshinori Nakayama, Wenjun Ouyang and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information

Reporting Summary

Source data

Source Data

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Cite this article

Xu, H., Agalioti, T., Zhao, J. et al. The induction and function of the anti-inflammatory fate of T_H17 cells. Nat Commun 11, 3334 (2020). https://doi.org/10.1038/s41467-020-17097-5

Download citation

Received: 03 October 2019
Accepted: 11 June 2020
Published: 03 July 2020
DOI: https://doi.org/10.1038/s41467-020-17097-5

This article is cited by

The dynamic shifts of IL-10-producing Th17 and IL-17-producing Treg in health and disease: a crosstalk between ancient "Yin-Yang" theory and modern immunology
- Huantian Cui
- Ning Wang
- Fudi Wang
Cell Communication and Signaling (2024)
Ileum tissue single-cell mRNA sequencing elucidates the cellular architecture of pathophysiological changes associated with weaning in piglets
- Wenjie Tang
- Yifan Zhong
- Haifeng Wang
BMC Biology (2022)
miR-2337 induces TGF-β1 production in granulosa cells by acting as an endogenous small activating RNA
- Lingfang Wang
- Xing Du
- Qifa Li
Cell Death Discovery (2021)
Functional heterogeneity of CD4+ T cells in liver inflammation
- Franziska Muscate
- Anna Woestemeier
- Nicola Gagliani
Seminars in Immunopathology (2021)

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.